Clinical Trials in Los Angeles

Showing 6641-6660 of 16,901 trials

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

NCT02823041

This is a confirmatory randomized controlled trial of the efficacy of a novel intervention combining neuroplasticity-based cognitive training with aerobic exercise, compared to the same systematic cognitive training alone. Treatment occurs for 6 months after randomization, with a followup assessment at 12 months. The investigators hypothesize that combining neuroplasticity-based computerized cognitive training and neurotrophin-enhancing physical exercise will produce neurotrophin increases and cognitive and functional improvements, even relative to cognitive training alone. The investigators target the period shortly after a first episode of schizophrenia to maximize the generalization of cognitive improvement to functional outcome, before chronic disability is established.

SchizophreniaSchizophreniform DisorderSchizoaffective Disorder

University of California, Los Angeles100 participantsStarted Oct 2016

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

NCT04940390

Study STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

MigraineMigraine With AuraMigraine Without Aura

Satsuma Pharmaceuticals, Inc.1,591 participantsStarted Jun 2021

Chandler, Arizona, United States • Phoenix, Arizona, United States • Tempe, Arizona, United States +124 more locations

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine

Find Trials by Condition in Los Angeles

Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

Multifaceted Depression and Cardiovascular Program

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Green Sun Medical Dynamic Brace

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals

Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

Adolescent Idiopathic Scoliosis Outcomes Database Registry

Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy

CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients

Early Caries Lesion Management Observational Study

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma